glp-1 patent The Heavy Price of Drugs: How Financialization Drives Pharmaceutical Abuse and Health Inequities for GLP-1 Therapies – I-MAK The Heavy Price of GLP-1

Beyond Resolutions: Sustainable Weight Loss with GLP-1 Medications If you started your health journey with us back in early January, you have likely reached an interesting crossroad

Important context: While worsening heart failure events were meaningfully reduced, cardiovascular deaths were numerically higher in the tirzepatide group at 2.2% versus 1.4% in the placebo group

Myocardial infarction (MI) or myocardial ischemia/reperfusion (MI/R) injury Park et al

The findings presente the promise of MF-based neuromodulation as a non-invasive, highly targeted therapeutic strategy for conditions such as epilepsy, movement disorders, and neurodegenerative diseases, with potential applications in chronic pain management and future clinical interventions

Restrepo, R

Overweight and obesity, type 2 diabetes, and addiction are all linked with bipolar disorder